Manufacturer record
Ambrosia Pharma: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Ambrosia Pharma (Jammu & Kashmir) was declared Not of Standard Quality in June 2021. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: AVG-401, Amitraz Dip Concentrate Liquid BP Vet. (AMTRAZ) (exp Dec 2022). RDTL Chandigarh (state lab) found it not of standard quality: Assay of Amitraz. Listed in the June 2021 alert.
Records by type
1 record linked to Ambrosia Pharma in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Amitraz Dip Concentrate Liquid BP Vet. (AMTRAZ) | Batch AVG-401Mfg Jan 2021 · Exp Dec 2022 | Assay of AmitrazAssay | RDTL ChandigarhState lab | Jun 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.